🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 for type 1 diabetes as adjunct — need advice Page 8

GLP-1 for type 1 diabetes as adjunct — need advice

SarahChen_PharmD Fri, Jan 31, 2025 at 10:02 PM 40 replies 1,803 viewsPage 8 of 8
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Aug 21, 2025 at 11:42 PM#36
wendy_avl said:
Practical: whatever you change, write down the date and the reason.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

50 0denise_HTX, raj_cambridge, ingrid_STO and 47 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Sep 2, 2025 at 10:53 AM#37

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

49 24traveltech_sara, AttorneyGrant, DebRD_ATL and 46 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Sep 13, 2025 at 9:58 PM#38
Dr.Martinez said:
The useful move here is to separate what is established from what is widely repeated.

This is my experience too, for whatever a second data point is worth.

48 23MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Sep 25, 2025 at 8:56 AM#39
Dr.Martinez said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: Sep 25, 2025 at 2:56 PM
47 22tammy_FL, Dr.LipidDallas, alex_tucson and 44 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Oct 6, 2025 at 7:47 PM#40

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

25 0EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 22 others
Reply Quote Save Share Report
1678

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register